↓ Skip to main content

A first-in-human study of the novel metabolism-based anti-cancer agent SM-88 in subjects with advanced metastatic cancer

Overview of attention for article published in Investigational New Drugs, March 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 1,266)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
9 news outlets
twitter
2 X users
patent
3 patents

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
22 Mendeley
Title
A first-in-human study of the novel metabolism-based anti-cancer agent SM-88 in subjects with advanced metastatic cancer
Published in
Investigational New Drugs, March 2019
DOI 10.1007/s10637-019-00758-8
Pubmed ID
Authors

Jeanetta Stega, Marcus S. Noel, Alexander G. Vandell, Damian Stega, Giuseppe Del Priore, Steve Hoffman

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 14%
Student > Bachelor 2 9%
Student > Master 2 9%
Student > Ph. D. Student 2 9%
Lecturer 1 5%
Other 3 14%
Unknown 9 41%
Readers by discipline Count As %
Nursing and Health Professions 3 14%
Medicine and Dentistry 3 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Agricultural and Biological Sciences 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 2 9%
Unknown 10 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 78. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2023.
All research outputs
#554,344
of 25,743,152 outputs
Outputs from Investigational New Drugs
#7
of 1,266 outputs
Outputs of similar age
#12,461
of 365,541 outputs
Outputs of similar age from Investigational New Drugs
#1
of 24 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,266 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,541 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.